(NASDAQ: PRE) Prenetics Global's forecast annual revenue growth rate of 113.53% is forecast to beat the US Diagnostics & Research industry's average forecast revenue growth rate of 9.87%, and it is also forecast to beat the US market's average forecast revenue growth rate of 24.35%.
Prenetics Global's revenue in 2026 is $92,390,000.On average, 5 Wall Street analysts forecast PRE's revenue for 2026 to be $3,328,920,278, with the lowest PRE revenue forecast at $3,075,808,943, and the highest PRE revenue forecast at $3,747,397,685.
In 2027, PRE is forecast to generate $5,224,892,918 in revenue, with the lowest revenue forecast at $4,838,307,539 and the highest revenue forecast at $5,698,042,374.